Pancreas Cancer
324
94
124
91
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
27 trials with published results (8%)
Research Maturity
91 completed trials (28% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.0%
29 terminated out of 324 trials
75.8%
-10.7% vs benchmark
4%
14 trials in Phase 3/4
30%
27 of 91 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 91 completed trials
Clinical Trials (324)
Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent
Autologous CAR-T Cells Targeting B7-H3 in PDAC
First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
Statewide Unified Network for Remote Intervention of Strength and Exercise
Promoting CT Engagement for Pancreatic Cancer With App
MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma
Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery